MarketMedicines Discovery Catapult
Company Profile

Medicines Discovery Catapult

The Medicines Discovery Catapult (MDC) is the United Kingdom's catapult centre for medicine research and innovation, headquartered at Alderley Park in Cheshire.

History
The intention to form the company was announced by the Chancellor on 13 July 2015 with funding of £5m, on a visit to Cheshire. It would be part of the Northern Powerhouse initiative. The Medicines Technologies Catapult was established in December 2015, On 1 March 2016 its name changed to the Medicines Discovery Catapult. Further funding of approximately £10m per year was secured from Innovate UK for the years 2018 to 2023. The Leeds site is now the Leeds Centre for Personalised Medicine and Health. == Activities ==
Activities
A not-for-profit company, the MDC works with a range of UK innovators to advance projects and products towards clinical impact. In 2019, the company stated that it worked in four sectors: By 2021, this centre employed over 700 staff and had a stated capacity of 80,000 test samples per day. == Key people ==
Key people
Dr Robin Brown has been the company's chairman since July 2018; The company has no shareholders. ==See also==
tickerdossier.comtickerdossier.substack.com